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1 |  INTRODUCTION
Elderly people are acutely aware of the progressive aging, 
but quantifying and characterizing physiological aging is 
less intuitive. Nonetheless, assessment of aging and de-
termination of aging type by analyzing metabolites in 
biofluids, such as blood and urine, may help us to un-
derstand multifaceted aging of the human body.1-16 Age-
dependent changes of metabolite abundances may be 
valuable in identifying molecular causes of impaired organ 
functions.12 Technology that enables simple and rapid mea-
surement of urinary metabolites, which can be collected 
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Abstract
Metabolites in human biofluids document the physiological status of individuals. We 
conducted comprehensive, non-targeted, non-invasive metabolomic analysis of urine 
from 27 healthy human subjects, comprising 13 young adults (30 ± 3 years) and 14 
seniors (76 ± 4 years). Quantitative analysis of 99 metabolites revealed 55 that displayed 
significant differences in abundance between the two groups. Forty-four did not show a 
statistically significant relationship with age. These include 13 standard amino acids, 5 
methylated, 4 acetylated, and 9 other amino acids, 6 nucleosides, nucleobases, and deriva-
tives, 4 sugar derivatives, 5 sugar phosphates, 4 carnitines, 2 hydroxybutyrates, 1 choline, 
and 1 ethanolamine derivative, and glutathione disulfide. Abundances of 53 compounds 
decreased, while 2 (glutathione disulfide, myo-inositol) increased in elderly people. The 
great majority of age-linked markers were highly correlated with creatinine. In contrast, 
44 other urinary metabolites, including urate, carnitine, hippurate, and betaine, were not 
age-linked, neither declining nor increasing in elderly subjects. As metabolite profiles 
of urine and blood are quite different, age-related information in urine offers additional 
valuable insights into aging mechanisms of endocrine system. Correlation analysis of 
urinary metabolites revealed distinctly inter-related groups of compounds.
K E Y W O R D S
creatinine, glutathione, human endocrine aging, LC-MS, non-targeted metabolomics, pseudouridine, 
urinary age markers
[Correction added on November 19, 2020, after first online publication: affiliation 2 has been updated correctly.]  
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non-invasively, has certain advantages over methods using 
blood. Urinary metabolites are promising biological sam-
ples for monitoring health parameters if the metabolic 
processes resulting in production of those metabolites 
can be fully understood. To date, few comprehensive ap-
proaches to investigate human urinary metabolites in aging 
have been reported.13,15,17 Urination is a primary route by 
which the body eliminates water-soluble waste products. 
Accordingly, urine has been broadly utilized for diagno-
sis of renal dysfunction in diverse kidney diseases.18-23 
Nonetheless, because urinary metabolites originate in all 
organ systems, urinary metabolites may be useful to ex-
amine human aging in a synthetic way. In this study, we 
analyzed urinary metabolites in young and elderly subjects, 
using comprehensive metabolomics to identify metabolites 
linked to aging. Striking correlations of many urine metab-
olites with age were found. Previously creatinine, the waste 
product from muscle and other organs, was identified as an 
age-related factor.1,2,20 Subsequently, dimethyl-guanosine, 
decanoyl-carnitine, N-acetyl-aspartate, and tryptophan 
were reported to decline in urine of elderly subjects.15,17 
In this study, we identified many more age-dependent 
and age-independent metabolites using comprehensive, 
non-targeted analysis of urine compounds. Fifty-three 
compounds were found to decline, while two compounds 
increase in urine of elderly subjects.
2 |  MATERIAL AND METHODS
2.1 | Participants and sample collection
Fourteen elderly (69–81 years) and 13 young (25–38 years) 
healthy people participated as subjects in this study (Table 
S1). Serum clinical renal markers were measured at Falco 
Biosystems Ltd. (Kyoto, Japan). Values of all participants 
were within normal ranges (urea nitrogen, 8–20  mg/dL; 
creatinine, female 0.47–0.79 and male 0.61–1.04  mg/dL). 
Measurements of metabolites in first morning urine are 
more consistent than random daytime sampling to monitor 
metabolites. Intra-individual coefficients of variation in first 
morning urine and 24-h collected urine are similar to those 
previously reported.24 Midstream urine samples for metabo-
lomic analysis were taken in the morning at home, immedi-
ately after awakening. Subjects were asked to ensure at least 
8  h of fasting prior to sampling. During fasting, they took 
water freely. After collection, urine samples were brought to 
the laboratory within 3  h. 0.2  mL urine were immediately 
quenched in 1.8 mL of 55% methanol at −40°C. This rapid 
quenching step stabilizes metabolites and maximizes re-
producibility of metabolomic data. Two internal standards 
(10 nmol of HEPES and PIPES) were added to each sample. 
After brief vortexing, samples were transferred to Amicon 
Ultra 10-kDa cut-off filters (Millipore) to remove proteins 
and cellular debris. After sample concentration by vacuum 
evaporation, each sample was re-suspended in 40 µL of 50% 
acetonitrile, and 1 µL was used for each injection into the 
LC-MS system, as described.12,25
2.2 | Ethics statement
Written, informed consent was obtained from all donors, in 
accordance with the Declaration of Helsinki. All experiments 
were performed in compliance with relevant Japanese laws 
and institutional guidelines. All protocols were approved 
by the Human Subjects Research Review Committee of 
the Okinawa Institute of Science and Technology Graduate 
University.
2.3 | Chemicals and reagents
Standards for metabolite identification were purchased from 
commercial sources as described previously.12,26-28
2.4 | LC-MS analysis and data processing
Urinary metabolites were analyzed using an Ultimate 3000 
DGP-3600RS HPLC system (Thermo Fisher Scientific) cou-
pled to an LTQ Orbitrap mass spectrometer (Thermo Fisher 
Scientific), as described.12,25 Briefly, LC separation was per-
formed on a ZIC-pHILIC column (Merck SeQuant, Umea, 
Sweden; 150 mm × 2.1 mm, 5 µm particle size). Acetonitrile 
(A) and 10  mM ammonium carbonate buffer, pH 9.3 (B) 
were used as the mobile phase, with a linear gradient elution 
from 80% to 20% A over 30 min, at a flow rate of 100 µL/
mL. The mass spectrometer was operated in full-scan mode 
with a 100-1000 m/z scan rate and automatic data-dependent 
MS/MS fragmentation scans. For each metabolite, we chose 
a singly charged, [M + H]+ or [M-H]−, peak (Table S2). Peak 
detection and identification of metabolites were performed 
using MZmine 2 software.29 Detailed data analytical pro-
cedures and parameters have been described previously.26 
Normalized peak area was calculated from the following 
formula: Normalized peak area  =  (Raw peak area of each 
metabolite/Raw peak area of creatinine) × 1000.
2.5 | Peak identification and characteristics
We analyzed 99 urine metabolites that were confirmed 
using standards or MS/MS analysis.12,26-28 Metabolite 
abundances were classified into 3 groups (H, M, and L), 
according to their peak areas. H denotes compounds with 
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high peak areas (>108 AU), M with medium peak areas 
(107  ~  108 AU) and L with low peak areas (<107 AU) 
(Table S3).
2.6 | Statistical analysis
Peak data processed by MZmine 2 were exported into spread-
sheet format and analyzed with R statistical software (http://
www.r-proje ct.org). Statistical analysis was performed using 
the Mann Whitney U-test. Statistical significance was estab-
lished at p < 0.05. Q-values were calculated from p-values 
using the Benjamini-Hochberg method.
2.7 | Data and materials availability
Raw LC-MS data in mzML format are accessible via the 
MetaboLights repository (URL: http://www.ebi.ac.uk/metab 
olights). Data for the 27 volunteers are available under acces-
sion number MTBLS1407.
3 |  RESULTS
3.1 | Collection of urine samples
Samples of morning urine, immediately after awaking, 
were collected from healthy volunteer subjects (elderly, 
75.8 ± 3.9 years, and young, 30.6 ± 3.2 years; Table S1 shows 
gender, BMI, urea nitrogen, and creatinine) in Onna Village, 
Okinawa, Japan. Precautions taken for sample collection are 
described in the Material and Methods. Basic data analytical 
procedures were similar to those previously described.12,25,26
3.2 | 99 urine metabolites identified
Ninety-nine urinary metabolites were identified and quanti-
fied using liquid chromatography-mass spectrometry (LC-
MS) and the peak identification software MZmine 226,29 
(chromatogram and mass spectrum data in Table S2, and 
 p-values, q-values, and age markers in Table S3). These 
compounds were subdivided into 12 groups, containing 
standard amino acids, methylated amino acids, acetylated 
and other amino acids, nucleosides, nucleobases, and their 
derivatives, sugar derivatives, sugar phosphates, vitamins 
and coenzymes, choline and ethanolamine derivatives, car-
nitines, organic acids, and an antioxidant. Small amino acids, 
such as glycine and alanine, were not detected in our analysis 
due to the mass cutoff (100 m/z) used. Levels of individual 
compounds, categorized by abundance as H (high, >108), M 
(medium, 107–108) or L (low, <107), were estimated based 
upon mass spectroscopic peak area.12,27 Raw abundance data 
are shown in the database.
Some compounds varied widely among individuals and 
are denoted as H-L, H-M or M-L. According to abundance, 
there were 7 H, 19 H-M, 7 H-L, 5 M, 45 M-L and 16 L com-
pounds. Twenty-six urinary metabolites belonged to the 
abundant class (H or H-M), the great majority of which were 
amino acids and their derivatives, such as the methylated 
amino acids, betaine and dimethyl-arginine, but they also 
included nucleosides, such as pseudouridine and N-methyl-
guanosine. In blood, sugar phosphates and methylated amino 
acids were enriched in red blood cells.12,27 Below, we show 
that about half of all urinary metabolites are age-related.
3.3 | 55 urinary compounds are less 
abundant in elderly samples
Of 99 urinary metabolites assayed in 27 subjects, 55 showed 
statistically significant differences between young and elderly 
subjects (p-values, 0.00003 < p < 0.05) (Figure 1; Table 1A). 
Thus, about half (55/99) of the urinary metabolites are age-
linked to aging, with all but glutathione disulfide (GSSG) 
and myo-inositol becoming less abundant in elderly subjects. 
To verify statistical significance of metabolite abundances, 
we also calculated q-values, as an estimate of false discov-
ery rates. Q-values shown in Table S3 are consistent with 
p-values of 50 age-related compounds. Five compounds (hy-
poxanthine, myo-inositol, lysine, butyro-betaine, keto(iso)
leucine) had q-values of ~0.08. In contrast, the remaining 44 
compounds (Tables 1B and S3), did not differ significantly 
between young and elderly (Figure S1).
3.4 | Creatinine is an age marker
In clinical settings, creatinine is often used for normaliza-
tion, as it is abundant and stable. Creatinine is also known 
as a urinary age marker.1 We found that creatinine and many 
other age markers decline in elderly subjects, possibly due 
to similar causes. If creatinine is used for normalization of 
F I G U R E  1  Dot plot profiles of 55 age-linked urine compounds, which comprise 11 groups, in samples from 27 individuals are shown. Pale 
red and azure dots represent elderly and young subjects, respectively. Bars represent medians in each group. The peak abundance of compounds 
and the ratio of median value between elderly and young are shown in Table 1A and 1B. P-values were obtained using the non-parametric Mann 
Whitney U-test. Fifty-three of 55 compounds were more abundant in urine of young subjects, while two (myo-inositol and GSSG) were more 
abundant among the elderly [Colour figure can be viewed at wileyonlinelibrary.com]
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3 age-linked metabolites (dimethyl-guanosine, tryptophan, 
N-acetyl-aspartate), such age-linked differences vanish 
for tryptophan and N-acetyl-aspartate (Figure S1A), while 
dimethyl-guanosine abundance in elderly urine diminished 
to a little more than half that of young adult samples. If 
age-independent metabolites such as urate, citrate, caffeine, 
betaine are normalized against creatinine, their abundances 
in elderly urine exceeded those in young adult samples, 
causing false assignments (Figure S1B). Thus, for 44 urine 
age-independent compounds, creatinine cannot be used for 
normalization.
Since urine concentration fluctuates daily due to factors 
such as water intake, it is common to use creatinine concen-
tration for correcting the measured values. If metabolites 
of interest are age-linked, normalization against creatinine 
might be appropriate. If not, correction of quantitative data 
with creatinine levels might miss certain compounds with 
interesting features. To check the consistency of urinary me-
tabolite concentrations in first morning urine, we examined 
the diurnal variation of 8 representative metabolites that were 
less abundant in urine of elderly people. Three young sub-
jects were asked to collect urine every morning for 5 days. 
Our data indicated that the diurnal variation of these metabo-
lites was negligible in the same person (Figure S2).
3.5 | Glutathione increased in elderly urine 
while other compounds declined sharply
Two compounds, myo-Inositol and GSSG, were 1.34- and 
6.96-fold, more abundant, respectively, in elderly samples 
(Table 1A). The increase of GSSG was striking, though its 
abundance in urine was rather low (Figure S3A). GSSG (and 
glutathione, GSH) was virtually absent in urine of young 
adults, while it was abundant in elderly samples. myo-Ino-
sitol, like GSSG increased in elderly urine (Figure S3H), a 
phenomenon which cannot be explained at present.
Creatinine was abundant in urine of young subjects 
(Figure S3B), but together with pseudouridine, isoleucine, 
leucine, dimethyl-guanosine and N-methyl-guanosine, it de-
clined sharply in urine of elderly subjects (Figure S3C–G). In 
fact, many metabolites diminished to less than half in urine of 
elderly subjects [fructose-1,6-diphosphate (0.14), carnosine 
(0.34), glycerophosphate (0.32), 2- and 3-hydroxybutyrate 
(0.33, 0.27, respectively), and octanoyl-carnitine (0.40)].
3.6 | Highly correlated age-linked urinary 
metabolites
To understand relationships among urine metabolites, 
Pearson's correlation coefficients were calculated from abun-
dance data for all 55 age-linked urinary metabolites of all 
27 subjects. The highest correlation, 0.92, was obtained for 
isoleucine – leucine and N-methyl guanosine – dimethyl 
guanosine (Figure 2A). This is probably due to their simi-
lar chemical structures and proximity in biochemical path-
ways (see below and KEGG, https://www.genome.jp/kegg/). 
However, correlation values (0.91) obtained for glycerol-
phosphate – 3-hydroxybutyrate, pseudouridine – 2-hydroxy-
butyrate, and pseudouridine – isoleucine clearly have a 
different explanation.
Pairwise correlation analyses revealed 19 pairs of com-
pounds with correlation coefficients >0.85 (Figure 2). 
These show a network consisting of two groups, one cen-
tered around pseudouridine and the other around isoleucine 
(Figure 2). Creatinine is linked to both. This suggests that 
compounds within each of these groups may be metaboli-
cally linked.
The high correlation between pseudouridine and isoleu-
cine seems to be a key connection between two groups of 
metabolites. Additionally, the connections of creatinine to 
pseudouridine and 3-hydroxybutyrate, and of isoleucine to 
glutamine required further explanation. In the case of a cre-
atinine-related network, 11 metabolites have correlation co-
efficients from 0.71–0.84 (Figure 2A). Creatinine, a known 
waste product from muscle,30,31 is thus correlated with a 
broad array of urinary metabolites.
When urinary compounds with correlation coefficients 
larger than 0.7 were selected, the majority of age-linked me-
tabolites formed a large network consisting of 42 metabo-
lites from 55 age-linked compounds (Figure S4). Since all 
age-linked metabolites displayed p-values <0.05 in dot plot 
profiling, the fact that the great majority (42/55  =  76%) 
form such a large age-linked correlation network is quite 
impressive.
3.7 | Some age-linked metabolites were not 
highly correlated
Thirteen age-marker compounds showed only weak corre-
lations (<0.7) with the other 42 age-linked urinary metabo-
lites (Figure S5). Aspartate, a standard amino acid having an 
acidic side chain, showed maximal, but inverse correlation 
with GSSG (−0.67). Aspartate has a correlation coefficient of 
0.65 with N-acetyl-aspartate, indicating that structural simi-
larity might partly explain the weak correlation. S-adenosyl-
homocysteine did not show correlation values higher than 
0.48 (octanoyl-carnitine). Lysine, dimethyl-lysine, trimethyl-
lysine, and N6-acetyl-lysine did not show high correlation 
coefficients. Fructose-1,6-diphosphate showed a maximal 
correlation value (0.58) with pentose-phosphate and gluco-
nate. Whether these metabolites decline in elderly subjects 
as a consequence of aging or as a cause of it, remains to be 
investigated.
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T A B L E  1 A  List of 55 aging-linked compounds that showed a significant difference in abundance between young and elderly people. The 
abundance of compounds (peak area) displayed: H, high peak areas [>108 AU (arbitrary unit)]; M, medium peak areas (107 ~ 108 AU); L, low peak 
areas (<107 AU). The peak ratio was calculated using the median of peak abundance in elderly and young people, respectively
Category Compound Peak abundance Ratio (elderly/young)

























Organic acids (2) 2-Hydroxybutyrate M-L 0.33
3-Hydroxybutyrate M-L 0.27
Antioxidant (1) Glutathione disulfide L 6.96
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3.8 | Heatmap analysis of urinary 
metabolites linked to aging
We then employed a heatmap to visualize the quantitative 
profile of age-linked urinary metabolites in individual sub-
jects (Figure 3). Since most of these metabolites declined in 
the elderly, matrix color represents metabolite abundance for 
individual subjects. Explanation of heatmap patterns is given 
in the legend of Figure 3. Thus, a heatmap of urinary metabo-
lites graphically illustrates the degree of urinary metabolite 
aging for individual subjects, so that subjects may be com-
pared one with another. Two subjects (elderly 11, 81F and 
young 15, 33 M) showed patterns remarkably like those of 
the opposite age group.
3.9 | Principal component analysis of age-
linked metabolites
Implications of urinary compounds in aging should also be 
cross-examined using results of blood compound analyses. 
However, as these compounds decrease in urine of elderly 
people, the results are consistent with actual aging. Some 
urinary metabolites may be implicated in sustaining health 
and slowing aging. To integrate quantitative metabolite 
abundance data from individual subjects, abundances of 
these 55 age-related metabolites were subjected to principal 
component analysis (PCA).25,32 Subjects were separated into 
2 groups representing negative and positive values of prin-
cipal component (PC) 1, respectively (Figure 4A). One el-
derly subject 11 (81F) was in the middle of the young group 
and one young subject 15 (33 M) was in the group of elderly 
subjects in the PCA plot (Figure 4A). These are consistent 
with results plotted in the heatmap (Figure 3). The PC1 score 
and chronological age of the subject were highly correlated 
(r = 0.80) (Figure 4B).
3.10 | Negative correlation between 
GSSG and age-linked metabolites
GSSG showed significant negative correlations with some 
age-linked metabolites (N-acetyl-aspartate, N-methyl-
guanosine, dimethyl-guanosine, pseudouridine, quinolinic 
acid, creatinine, N-methyl-histidine, etc.) (Figure 5A). While 
the oxidized disulfide form was detected in elderly samples, 
but the reduced form was not detected in young or elderly 
samples. Thus only the inactive form of glutathione was de-
tected in elderly samples. A possible interpretation is that the 
active reduced form glutathione (GSH) may be very reac-
tive and short-lived as a metabolite (see Discussion). The 
abundance of GSSG in 27 subjects is shown together with 
N-acetyl-aspartate, N-methyl-guanosine, dimethyl-guano-
sine, pseudouridine, and chronological age of subject (Figure 
5B-F). GSSG was low to undetectable in 5 young subjects, 
but accumulated in elderly samples (Figure 5F).
GSSG showed different degrees of abundance in different 
subjects, and was virtually absent in young subjects, but in 
elderly subjects, its abundance increased and paralleled the 
abundance of creatinine in young subjects (Figure S3A,B). 
Thus GSSG abundance was inversely related to aging. The 
reason for this increase of GSSG in elderly urine is probably 
due to the absence or declining effectiveness of a mechanism 
to metabolize and reprocess GSSG by the elderly. Such a re-
ductive mechanism does exist in young subjects; however, 
the redox environment regarding glutathione appears to be al-
tered during aging. Inability or declined efficiency to reduce 
oxidized GSSG at any recycling step may accelerate aging.
Category Compound Peak abundance Ratio (elderly/young)











Quinolinic acid M-L 0.44
S-Adenosyl-homocysteine L 0.75
T A B L E  1 A  (Continued)














Sugar phosphate (1) Glucose−6-phosphate L 0.78
Vitamins and coenzymes (3) Pantothenate H-M 0.79
4-Aminobenzoate H-L 3.04
Nicotinamide M-L 0.85




























Acetylated amino acids (2) N-Acetyl-glutamate M-L 0.71
N-Acetyl-(iso)leucine M-L 0.68






T A B L E  1 B  List of 44 metabolites 
that did not show a significant difference 
in abundance between young and elderly 
people
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4 |  DISCUSSION
We initially investigated metabolomics of a simple model 
eukaryote, fission yeast (Schizosaccharomyces pombe) using 
yeast genetic technology to identify and determine metabo-
lite profiles in wild type and mutant cell extracts,28,33-37 later 
embarking on human blood metabolomics.12,25-27 By adapt-
ing the software MZmine 2 for metabolite identification,29,38 
we found that metabolomics of fission yeast and humans are 
surprisingly similar in regard to metabolite composition.27 
Metabolites detected in fission yeast and human whole blood 
were 75% identical. Given this unexpected similarity, we 
adapted our techniques to human blood metabolites to better 
understand health, disease, and longevity.12,25-27 We then un-
dertook human fluids collected non-invasively, such as urine 
and saliva.
F I G U R E  2  Correlation network among age-linked compounds. (A) Values indicate correlation coefficients between paired compounds. 
Highly correlated pairs of aging markers (r > 0.85) are indicated with red circles. The most highly correlated pairs are indicated by green (0.92) and 
red arrows (0.91). (B) Interrelated compounds form a network. Correlations (r > 0.90) are highlighted in yellow. Creatinine was correlated with 
both groups (r = 0.74–0.84, shown in gray) [Colour figure can be viewed at wileyonlinelibrary.com]
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4.1 | Distinction of aging information 
between blood and urine
Urinary metabolites offer a valuable, non-invasive means of 
obtaining age-related information. The present results sug-
gest that urinary age information may be distinct from that ob-
tainable from blood. Blood metabolites derived from plasma 
and red blood cells of elderly subjects reflect a decrease in 
antioxidant production and muscle activity, or increasing 
inefficiency of nitrogen metabolism.12 Blood of frail elderly 
provided aging information on decline of locomotive, cogni-
tive and oxido-reductive ability.25
In this study, we identified 55 age-related metabolites. 
Many of them are highly correlated. In urine, creatinine has 
been well established as an age marker.1,2 Roughly a half of 
urine metabolites including creatinine are highly correlated, 
forming a large network. These 55 urine metabolites include 
anti-oxidants, amino acids and modified sugars, and metab-
olites of nucleosides, organic acids, and carnitines (Figure 
F I G U R E  3  Heatmap representing urinary metabolic profiles of elderly and young subjects. Standardized data for each metabolite are shown 
for 27 subjects using a color matrix representing relative abundance data of 55 urinary aging markers. Numerical values indicate the t-score, a kind of 
standardized score. The mean and standard deviation are 50 and 10, respectively. Color intensity of the cells reflects the t-score. The mean and standard 
deviation are 50 and 10, respectively. Color intensity of the cells reflects the t-score, indicating levels higher than average. T-score <40 is white, low; 
40 ~ 50 is thin red, slight low; 50–60 is moderate red, slight high; >60 is deep red, high. Elderly samples to the left were mostly white or pale red (lower 
























































Antioxidant Glutathione disulfide ↑ 75.1 73.0 52.5 62.4 51.6 56.0 63.8 55.2 57.9 46.3 45.9 48.1 58.7 50.7 50.5 41.9 46.0 42.8 39.6 43.8 43.3 39.6 44.8 41.6 39.6 39.6 39.6
Sugar derivative myo-Inositol ↑ 54.5 42.6 52.8 40.5 49.1 72.6 41.6 75.7 50.0 47.4 51.5 54.2 76.1 46.1 39.4 52.0 40.4 41.3 50.6 44.7 46.9 49.0 44.3 48.6 48.1 50.1 40.0
Dimethyl-guanosine 37.6 40.6 48.1 42.0 45.7 36.2 29.0 43.5 48.3 51.8 55.0 43.9 43.2 43.5 39.9 63.4 50.1 57.3 73.2 58.4 48.7 59.6 62.4 55.6 56.6 62.9 53.4
N-Methyl-adenosine 36.4 56.3 39.6 55.8 37.7 41.2 44.8 37.8 35.3 48.1 63.6 38.1 47.5 46.2 55.4 55.1 51.2 56.7 61.8 43.2 68.1 59.2 64.9 48.9 49.9 41.1 66.2
Pseudouridine 36.2 39.0 49.6 40.7 46.0 45.9 36.6 42.4 40.7 48.9 58.0 41.2 40.9 43.4 42.5 69.8 50.2 55.8 71.5 65.5 60.1 50.1 53.5 60.7 48.6 62.6 49.9
N-Methyl-guanosine 38.1 39.2 47.6 36.5 45.3 41.5 39.9 38.2 44.8 52.4 52.6 41.6 44.3 36.1 42.2 61.7 50.0 58.3 73.1 57.3 55.5 60.6 58.1 54.8 60.7 66.4 53.3
Adenosine 38.4 41.7 41.4 41.5 50.4 42.1 39.5 45.2 49.2 56.5 56.8 45.1 28.5 47.8 41.8 67.2 48.1 66.0 51.9 49.0 49.4 63.4 58.5 68.0 44.1 64.9 53.6
Hypoxanthine 37.1 38.2 61.0 40.9 54.2 35.7 53.1 40.9 45.2 58.1 65.3 37.7 39.0 33.9 43.4 52.6 50.2 53.9 57.3 56.5 52.7 71.4 63.1 47.2 60.5 51.3 49.7
Gluconate 37.7 43.3 50.3 34.2 41.5 48.7 38.3 45.4 40.1 66.4 66.0 43.1 44.9 46.7 44.3 75.5 43.3 48.5 63.5 57.2 54.5 49.3 49.9 49.8 57.6 62.8 47.2
N-Acetyl-glucosamine 37.9 45.1 43.9 45.3 49.1 32.0 43.4 47.3 45.6 61.7 73.2 45.9 37.0 39.0 42.4 48.9 44.3 57.3 63.4 47.6 70.0 55.9 55.8 52.8 46.6 61.1 57.4
1,5-Anhydroglucitol 43.4 42.2 44.8 45.2 43.8 44.7 40.4 41.8 42.7 46.8 56.9 45.7 45.5 43.5 52.8 66.3 47.1 54.1 64.1 53.8 52.3 46.0 47.3 54.7 49.2 88.1 46.5
Glycerol-phosphate 42.1 42.7 59.4 42.9 44.6 45.1 42.7 42.4 44.4 44.7 57.4 43.3 41.7 45.9 43.5 61.1 49.6 47.7 51.0 86.9 54.3 47.6 54.9 55.0 43.8 67.1 48.2
Fructose-1,6-diphosphate 41.1 41.3 43.3 40.8 40.5 51.6 41.4 40.9 40.4 50.6 65.5 40.6 48.3 57.9 48.2 70.2 65.1 46.0 58.3 53.4 42.3 53.1 76.5 44.5 51.6 52.3 44.3
Fructose-6-phosphate 41.1 41.8 66.4 39.8 41.8 47.7 40.0 39.0 41.1 48.5 83.1 41.6 57.2 40.7 43.3 58.7 51.5 49.9 55.0 44.8 58.6 57.4 59.3 51.3 48.9 52.5 49.2
Pentose-phosphate 36.6 39.9 51.1 37.1 48.4 41.6 41.1 45.7 46.2 49.2 72.9 46.3 41.4 43.7 43.2 58.9 49.9 51.6 68.8 66.1 52.3 47.4 70.8 48.1 47.7 59.3 44.5
Phosphoglycerate 43.8 43.6 49.7 44.3 45.5 45.8 44.3 43.6 44.1 46.4 50.9 44.2 52.9 45.8 44.9 80.5 47.1 48.4 46.4 58.2 47.4 47.5 46.4 65.8 46.6 80.2 45.7
Glycerophosphocholine 44.5 51.8 60.4 42.5 44.9 40.6 45.6 37.3 49.6 48.3 32.9 46.1 33.6 44.0 50.1 43.1 49.6 63.3 73.8 54.0 61.6 56.8 68.8 44.1 57.6 48.1 57.0
Glycerophosphoethanolamine 39.4 41.1 56.6 40.9 44.5 44.6 41.2 46.6 49.7 41.9 64.1 43.9 38.8 45.0 44.2 46.7 45.5 51.8 51.1 61.7 49.3 56.9 81.9 52.5 47.1 69.6 53.5
(iso)Butyryl-carnitine 41.9 47.3 46.4 43.7 46.9 41.8 41.6 45.2 50.2 49.7 41.6 44.0 44.9 37.0 48.7 56.9 50.7 73.1 45.3 51.8 63.1 46.9 39.0 72.6 46.2 68.9 64.4
(iso)Valeryl-carnitine 49.4 47.0 57.2 37.4 43.4 39.0 45.5 46.7 49.1 42.4 41.8 46.6 51.2 35.8 52.1 47.7 55.3 64.4 57.7 51.7 77.5 41.2 41.0 64.7 47.9 69.7 46.3
Decanoyl-carnitine 48.8 42.2 49.3 40.2 44.8 39.4 41.5 44.4 40.5 50.8 48.7 46.1 50.0 36.8 40.6 59.0 47.1 63.0 64.0 77.6 71.6 46.6 47.2 53.9 47.5 60.1 48.4
Octanoyl-carnitine 53.5 43.9 52.1 38.1 38.1 36.3 40.4 40.2 44.4 54.9 42.8 40.8 44.1 36.6 52.6 58.6 45.8 50.0 65.2 72.6 58.4 51.3 61.0 69.8 48.8 56.5 53.2
2-Hydroxybutyrate 40.1 41.4 54.4 40.9 45.5 42.7 40.6 41.3 42.9 48.0 62.4 43.6 46.8 42.3 43.2 70.4 48.3 51.2 81.0 64.9 52.5 47.9 53.0 49.4 48.1 59.4 47.7
3-Hydroxybutyrate 40.2 40.4 57.7 41.8 45.4 48.9 40.4 40.0 42.2 42.8 56.9 42.7 49.1 41.9 41.3 63.1 47.6 52.6 64.6 83.5 57.6 48.4 48.4 56.6 46.9 58.9 50.1
Histidine 48.3 51.5 46.9 39.8 48.7 47.7 33.5 30.3 48.0 36.7 51.5 34.0 48.6 39.1 50.7 42.9 50.2 59.4 60.1 58.7 65.4 53.9 53.9 63.8 62.5 66.3 57.5
Phenylalanine 39.2 46.1 43.1 38.9 49.2 53.4 37.6 36.9 46.8 49.8 64.5 41.1 43.0 38.5 44.1 74.5 56.2 52.9 53.6 49.5 55.8 50.1 49.8 67.5 51.7 70.6 45.9
Tryptophan 41.8 44.8 51.3 40.3 49.8 52.5 35.2 35.4 48.7 42.3 60.2 38.9 48.7 38.0 45.9 70.5 49.8 58.8 56.6 61.5 59.1 46.4 52.7 73.8 44.4 59.6 42.8
Asparagine 44.0 49.0 45.2 37.1 49.3 60.2 31.5 33.1 54.6 46.4 53.4 41.9 46.7 40.9 42.0 66.1 45.6 50.3 58.6 48.7 53.4 53.9 47.1 75.8 61.1 63.9 50.1
Glutamine 41.8 45.5 40.9 42.2 44.7 50.6 35.8 40.1 42.2 46.0 64.3 42.7 41.3 43.4 43.5 68.7 54.2 57.8 60.0 57.1 63.6 47.5 44.7 55.5 50.7 76.7 48.7
Leucine 36.8 42.1 46.7 43.0 44.6 54.0 36.8 38.6 43.6 46.0 68.2 39.8 37.7 52.5 46.3 74.4 57.7 48.7 56.7 56.3 63.0 50.3 46.6 63.5 48.1 62.8 45.3
Lysine 49.2 53.4 47.3 42.0 56.1 47.2 42.3 43.3 43.3 42.5 56.0 44.3 44.5 43.1 46.3 62.1 90.0 45.3 44.7 54.7 48.6 44.5 54.0 59.1 42.7 58.7 44.7
Methionine 42.7 49.4 44.7 37.5 49.6 66.1 39.1 39.5 49.5 44.3 63.4 44.9 28.4 39.8 44.5 61.7 59.7 56.5 57.2 47.2 50.4 49.2 50.7 67.5 47.6 69.7 49.4
Serine 48.8 43.9 40.6 39.1 45.1 54.2 33.7 36.2 44.5 53.1 59.6 38.1 30.6 44.9 45.9 61.1 47.8 66.6 57.3 55.0 57.3 54.0 50.8 69.6 57.1 63.2 51.9
Threonine 46.1 44.8 48.6 42.9 47.1 72.5 33.0 39.2 42.7 48.4 54.5 41.1 42.8 38.9 39.5 58.5 49.5 63.6 62.2 49.7 59.0 45.5 46.4 68.3 49.0 66.9 49.1
Aspartate 34.5 40.0 43.4 44.7 50.4 42.0 38.5 43.3 46.8 57.1 52.3 41.9 44.9 49.0 49.9 34.9 48.5 71.5 54.6 50.7 50.3 76.2 48.7 53.6 58.4 58.8 65.1
Isoleucine 37.4 42.0 51.2 42.9 44.7 50.7 38.2 39.2 40.1 49.7 70.3 41.2 38.7 41.4 44.6 70.3 50.5 53.9 67.3 52.2 63.5 51.0 47.4 62.0 51.1 62.0 46.8
Valine 38.0 41.3 45.5 42.1 43.2 50.2 38.1 40.4 41.5 49.2 67.3 40.5 37.8 41.4 63.2 72.5 48.3 53.1 62.6 56.2 59.4 50.0 48.8 61.3 49.4 64.0 44.9
Dimethyl-arginine 35.0 46.5 54.9 45.0 50.6 43.0 38.6 40.5 51.0 40.1 49.2 44.4 59.4 39.9 53.3 55.7 60.2 40.4 45.0 64.5 60.2 52.7 43.4 72.0 41.0 73.0 50.8
N-Methyl-histidine 36.4 44.5 48.1 33.7 47.9 51.0 35.0 43.6 42.7 48.0 48.3 41.5 44.6 43.3 38.8 57.4 58.5 68.5 63.0 53.6 55.2 58.1 54.5 66.6 40.4 66.5 60.3
Trimethyl-lysine 41.8 42.3 49.9 41.8 44.0 49.5 37.5 53.4 46.8 51.4 42.8 50.2 48.7 45.6 46.5 49.1 54.9 54.2 49.4 55.3 39.6 60.1 51.6 91.8 49.2 57.0 45.3
Dimethyl-lysine 35.1 42.9 47.3 41.2 52.3 39.5 38.0 38.6 40.4 41.7 69.6 53.4 59.2 45.6 49.5 47.9 63.3 41.1 64.6 49.5 52.3 42.7 59.7 68.1 45.9 58.4 62.3
Butyro-betaine 43.5 48.7 49.1 41.2 54.7 41.5 44.0 49.4 49.9 42.8 42.8 52.3 44.7 40.8 61.8 45.8 46.0 51.6 51.9 45.5 75.4 44.3 44.0 68.4 45.4 78.9 45.6
N-Acetyl-arginine 39.5 26.2 50.4 36.4 56.3 63.8 32.0 38.8 51.3 47.0 51.4 38.6 53.2 51.6 45.5 53.5 57.4 56.6 42.3 48.2 53.5 65.1 57.7 61.1 65.1 58.0 49.5
N2-Acetyl-lysine 40.2 33.4 57.0 36.6 55.7 44.6 34.3 37.9 48.8 44.8 51.5 41.3 61.5 41.9 48.7 52.8 76.6 53.7 43.7 50.4 48.7 65.6 54.4 58.5 59.6 56.5 51.2
N6-Acetyl-lysine 37.0 53.7 42.9 49.7 41.1 57.8 33.0 33.9 37.1 56.0 50.3 38.3 50.5 38.7 65.6 63.1 57.2 43.5 54.8 52.4 45.3 68.2 58.2 63.8 47.6 55.4 54.9
N-Acetyl-aspartate 34.6 37.5 43.4 42.4 44.3 45.4 35.1 39.9 38.9 50.1 55.0 41.8 49.9 45.8 49.1 56.8 45.2 64.0 65.9 53.2 57.6 55.9 47.4 60.9 59.8 74.9 55.2
Creatinine 35.1 38.7 47.0 41.0 46.3 45.3 35.3 41.8 39.6 37.9 56.4 40.6 51.2 44.3 46.2 69.0 56.9 61.1 57.6 69.3 63.6 48.2 51.1 49.9 57.7 62.1 56.6
Indoxyl-sulfate 37.2 39.2 45.7 44.0 56.6 51.6 36.6 44.2 39.3 43.7 70.4 36.9 44.5 44.5 44.8 66.7 50.7 50.2 49.9 52.2 58.5 54.9 45.0 69.0 45.9 65.4 62.3
4-Guanidinobutanoate 39.7 41.4 40.0 40.6 41.8 78.6 37.9 41.3 47.6 58.3 63.9 45.5 42.7 43.1 49.9 49.4 54.4 49.1 47.1 46.6 61.9 51.8 42.0 61.6 68.0 55.0 50.8
Taurine 45.2 45.3 47.5 46.2 46.7 47.1 45.3 46.1 46.3 47.7 56.4 45.7 48.5 47.0 47.4 97.8 47.6 49.3 54.7 52.3 50.6 45.4 48.7 50.0 44.9 52.3 47.9
Carnosine 44.2 44.6 49.2 42.6 45.7 46.1 42.4 44.2 42.3 43.1 45.6 42.4 56.1 42.2 56.1 74.3 48.8 67.0 52.7 46.5 49.7 47.1 49.2 56.9 43.9 81.9 45.4
Keto(iso)leucine 41.4 43.2 52.2 42.5 43.9 52.5 41.4 42.3 43.9 43.9 66.2 43.5 88.0 43.5 43.7 51.6 48.0 47.3 66.1 52.8 54.6 45.8 52.4 51.9 50.6 50.1 46.7
Kynurenine 49.1 45.3 57.6 39.8 44.1 46.6 40.9 38.1 42.5 41.2 64.4 42.1 52.4 39.6 40.0 83.5 43.5 55.3 52.7 55.5 59.1 46.4 49.6 63.3 51.4 54.0 52.2
Quinolinic acid 37.0 39.0 49.7 38.9 50.5 39.5 36.7 44.4 38.2 62.1 57.3 39.7 47.0 42.1 44.3 47.3 45.1 56.4 66.1 70.3 64.0 58.1 54.6 51.7 52.1 66.8 51.1
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S4). Their abundances were reduced, except for the increase 
of GSSG and myo-inositol. Aging information obtained 
from urine metabolites may be useful in different ways from 
blood metabolites. Aging due to declining kidney function, 
for example, should be a primary research target. Since urine 
contains 99 compounds, many urinary metabolites such as 
vitamins (pantothenate and nicotinamide) and organic acids 
(citrate, malate) neither significantly decreased nor increased 
so that about a half of urinary metabolites are age-indepen-
dent (listed in Table 1B). In aged subjects, levels of protein, 
nucleic acid and lipid may decrease due to reduced physical 
activity,39-41 resulting in declining metabolite abundances in 
urine. Metabolite data may be considered as an overview of 
the physiological state of all tissues and organs. Hence these 
55 metabolites constitute a panorama of human aging as seen 
through urine composition. However, the role of age-inde-
pendent metabolites is much less understood. Their correla-
tions are also lower than those of age-linked metabolites. 
Further study is required.
4.2 | Glutathione disulfide, myo-
inositiol, and pseudouridine
Two exceptional urinary age metabolites, myo-inositol 
and GSSG, increased in elderly samples (1.34- and 6.96-
fold, respectively). myo-Inositol may be an important sec-
ond messenger when phosphorylated, causing changes in 
[Ca2+].42,43 In the correlation analysis, myo-inositol was 
not highly correlated with any other metabolite (Figure S5). 
Glycerophosphocholine and N-methyl-adenosine showed 
weak, negative correlations with myo-inositol (−0.47and 
−0.43, respectively, Figure S5). Implications of the myo-
inositol increase in urine of elderly people remain unclear.
GSSG that we detected was the inactive, oxidized form of 
GSH. It sharply increased in elderly urine (Figures 1 and S3A). 
The active SH form of GSH seems to be very unstable and it is 
difficult to prevent its degradation during preparation of urine 
(the present study) and blood samples.12 The active SH form was 
rapidly oxidized to an inactive disulfide form, which accumulated 
in elderly subjects, whereas in young subjects the disulfide form 
GSSG was hardly formed or undetected possibly due to rapid 
decay in the young body or sample. Consistently, GSSG was un-
detectable in urine of the five young subjects (Figure S3A). The 
abundance of GSSG was inversely related to concentrations of 
pseudouridine, creatinine, and dimethyl-guanosine, which were 
most abundant in young subjects (Figures 5 and S3). Thus the 
redox compound GSSG in urine appears to be appropriate as an 
age marker in urine of elderly subjects. In contrast, the high abun-
dance of the nucleoside, pseudouridine, seems to be emblematic 
of youth.
4.3 | Highly correlated urine metabolites
Fifteen metabolites, comprising two groups, are highly corre-
lated (correlation coefficients >0.85, Figure 2A,B). One includes 
nucleosides pseudouridine, dimethyl-guanosine, N-methyl-
guanosine and 2- or 3-hydroxybutyrate and the other group 
contains branched-chain and aromatic amino acids. Correlation 
within each group was high, but was not always high between 
the two subgroups (0.65 for pseudouridine and methionine, and 
0.56 for glycerol-phosphate and isoleucine; Figure 2). It remains 
to be determined what kind of functional connections exist be-
tween these two groups of metabolites in health and disease. In 
addition, a number of compounds showing correlation coeffi-
cients >0.70 are only remotely related structurally. Therefore, 
the high correlations of urinary compounds cannot all be easily 
F I G U R E  4  PCA of 55 aging markers. (A) Thirteen young and 
14 elderly subjects are shown in blue and red, respectively, with their 
subject numbers (indicated in the heatmap Figure 3). PC1 reflected 
the abundance of the compounds with strong correlation networks, 
such as pseudouridine and isoleucine (see Figure 2B and Figure 
S4). PC2 comprised metabolites that were not strongly correlated 
(glycerophosphocholine, S-adenosyl-homocysteine, etc.), but that 
were isolated from a strong correlation network. (B) PC1 score of each 
subject (X-axis) is plotted versus subject age (Y-axis). Subject 11 (F, 
age 81) is has a heatmap profile of a young person (Figure 3), while 
subject 15 (M, age 33) has an exceptionally elderly heatmap profile. 
The correlation coefficient is shown in the box [Colour figure can be 
viewed at wileyonlinelibrary.com]
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explained. While isoleucine, leucine, and valine contain hydro-
phobic side chains, glutamine, having a hydrophilic sidechain, 
showed correlation coefficients of 0.88-0.89 with isoleucine. 
Pseudouridine was highly correlated with 10 other compounds 
(>0.82), although we are unable to offer an explanation for this 
at present. The high correlation (0.83) between 2-hydroxybu-
tyrate and 3-hydroxybutyrate may be explained by their struc-
tural relatedness, but their correlations in the range of 0.6-0.82 
with 10 other compounds are difficult to explain.
4.4 | Thirteen metabolites linked by low 
correlation
Thirteen age-related metabolites that showed only low cor-
relation coefficients include myo-inositol, two regular amino 
acids (aspartate and lysine), methylated or acetylated amino 
acids, keto(iso)leucine, etc (Figure S5). Creatinine, an abun-
dant aging marker1 and an amino acid waste product in mus-
cle and other tissues showed higher correlations (0.71–0.84, 
Figure 2A,B). Its urinary content decreased to 43% in elderly 
samples (Tables 1A and 1B). More than half (31) of the de-
clining age markers in urine were amino acids (standard, 
methylated, acetylated, and other), and 6 more are nucleo-
sides, nucleobases, and their derivatives. Protein degrada-
tion and nucleic acid turnover seem to cause the change in 
urine of elderly persons. Pseudouridine is an oxidized tRNA 
component,44 perhaps important in catabolism of nucleosides 
and other compounds, as it is highly correlated with purine 
nucleosides (adenosine, guanosine, and inosine), muscle 
amino acids (isoleucine, creatinine), and organic acids (hy-
droxybutyrates, glycerol-phosphate). Pseudouridine is also 
F I G U R E  5  Scatter plots between GSSG and correlated compounds or age. (A) Ten metabolites with the relatively high correlations with 
GSSG are listed. Scatter plot of the peak abundance (×106 AU) between GSSG and N-acetyl aspartate (B), N-methyl guanosine (C), dimethyl 
guanosine (D), pseudouridine (E), and the age of the subject (F). Dots for young and elderly subjects are blue and red, respectively [Colour figure 
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abundant in blood, but the amount in urine is 15-fold higher. 
Pseudouridine showed high correlation coefficients with 10 
compounds (Figure 2) and its high abundance in urine may 
provide a convenient youth marker.
4.5 | An effective overview on aging 
by heatmap
Heatmap analysis of age-linked metabolites provides an effec-
tive overview of aging patterns using urinary metabolite pro-
files of individual subjects. Heatmap patterns are convenient for 
visualizing differences between young and aged subjects and 
also individual variations within and between groups (Figure 3). 
PCA was useful to categorize a group of subjects because of its 
capacity to integrate a large collection of data about various me-
tabolites. Elderly and young subjects were clearly separated into 
two populations, with two exceptions (subjects 11 and 15) in the 
present study (Figure 4). Exceptional individuals are of consid-
erable interest, by virtue of their persistent youth or premature 
aging, if these truly represent metabolic features in endocrine 
system. Their unusual profiles may be worthy of further inves-
tigation. Among 55 age-related urinary markers, 13 compounds 
did not show correlations >0.7 (Figure S5). We determined 
the correlations of these 13 compounds with all metabolites. 
Age-related metabolites such as myo-inositol, S-adenosyl-
homocysteine, N-methyl-adenosine, lysine, trimethyl-lysine, 
fructose-1,6-diphosphate, and glycerophosphocholine are only 
weakly correlated (~0.6) (Figure S5). Thus, high correlation is 
not necessarily required of age-related compounds. These me-
tabolites that are only remotely correlated are of interest to better 
understand the metabolic breadth of human aging.
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